12 Best Growth Stocks Trading in Oversold Territory
On June 11, Emily Roland, the Co-Chief Investment Strategist at Manulife John Hancock Investment Management, joined 'Squawk Box' on CNBC to discuss where investors can find opportunity...
Posts Tagged ‘NASDAQ:ROIV’
Guggenheim Remains Bullish on Roivant Sciences Ltd. (ROIV)
Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best healthcare stocks to buy with highest upside potential. Guggenheim lifted the price target on Roivant Sciences Ltd.
10 Best Healthcare Stocks to Buy with Highest Upside Potential
On June 1, Tom Lee, Fundstrat managing partner and head of research, and Fundstrat Capital CIO, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends, the...
15 High Growth Stocks to Buy and Hold for the Next Decade
High-growth stocks are getting more attention as investors look beyond the first wave of AI winners and try to identify companies that can still compound earnings over a longer...
Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2025 Earnings Call Transcript
Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2025 Earnings Call Transcript May 20, 2026Roivant Sciences Ltd. beats earnings expectations.
Roivant (ROIV) Climbs 15% on Swing to Profits
Roivant Sciences grew its share prices by 14.89 percent on Wednesday to close at $32.41 apiece, as investors took heart from its swing to profitability in the fourth quarter of...
10 Stocks With Insane Returns Right Now
On Wall Street, all three major indices finished in the green, led by the Nasdaq, up 1.54 percent, followed by the Dow Jones, jumping 1.31 percent, and the S&P 500, rising 1.08...
Here’s Why Roivant Sciences Ltd (ROIV) Rallied in Q1
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here...
10 Best Medical Stocks to Buy Under $30
On April 28, Reuters reported that the US Food and Drug Administration has introduced a new pilot program that would allow the agency to monitor clinical trial data in real...
15 Under-the-Radar Picks from David Einhorn That Are Quietly Dominating 2026
David Einhorn, the founder and president of Greenlight Capital, is widely regarded as one of the most intellectually rigorous and disciplined value investors of his generation...
Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential
Joseph Edelman, the billionaire chief of New York-based Perceptive Advisors, specializes in the biotechnology and life sciences sectors.
10 Must-Buy US Stocks to Buy Right Now
For some time, investors worried that the geopolitical conflict in the Middle East might drag on. That concern eased, at least temporarily, after U.S.
12 Best UK Stocks to Buy According to Hedge Funds
UK equities have spent much of the past decade trading at a discount to US peers, often overlooked in favor of faster-growing U.S. markets.
Citi Raises Roivant Sciences (ROIV) PT to $35 Following Positive Phase 2 Brepocitinib Data
Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the most promising low-cost stocks to buy now.
11 Most Promising Low-Cost Stocks to Buy Now
On February 7, Richard Bernstein, CEO of Richard Bernstein Advisors, joined 'The Exchange' on CNBC to discuss the state of equity markets, assessing which stocks are growing fast...
TD Cowen Remains Bullish on Roivant Sciences Ltd. (ROIV) – Here’s Why
Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best healthcare stocks under $50 to invest in. TD Cowen maintained a bullish outlook on Roivant Sciences Ltd.
12 Best Healthcare Stocks Under $50 to Invest In
On January 27, Jared Holz, healthcare equity strategist at Mizuho, appeared on CNBC’s 'Power Lunch' to talk about healthcare stocks and the new proposals around Medicare Advantage...
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2025 Earnings Call Transcript
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2025 Earnings Call Transcript February 6, 2026Roivant Sciences Ltd. beats earnings expectations.
Roivant Sciences (ROIV) Soars 19.4% as Pipeline Drugs Progress
Roivant saw its share prices jump by 19.4 percent week-on-week, hitting a new all-time high, as investors snapped up shares following encouraging results from its pipeline projects...
Leerink Raises Price Target as Roivant (ROIV) Accelerates Drug Development Pipeline
Roivant Sciences Ltd. (NASDAQ:ROIV) ranks among the best stocks under $25 to buy now.
15 Best Stocks Under $25 to Buy Now
Stock futures were marginally lower early December 29, as traders grabbed profits at record index levels and exited prominent technology names and precious metals following an...
Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2026 Earnings Call Transcript
Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2026 Earnings Call Transcript November 10, 2025Roivant Sciences Ltd. beats earnings expectations.
Do You Believe in the Growth Prospects of Roivant Sciences Ltd. (ROIV)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
13 Best Growth Stocks Under $25 to Buy Right Now
Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.
Roivant’s Brepocitinib Phase 3 Dermatomyositis Trial Hits Primary and All Key Secondary Endpoints
Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best stocks to buy under $20.
10 Best Stocks to Buy Under $20
On September 16, Ali Dibadj, Janus Henderson Investors CEO, joined 'Squawk Box' on CNBC to discuss the latest market trends and suggest that small and mid-cap stocks have enormous...
Roivant Sciences (ROIV) Hits New All-Time High as Drug Candidate Clinical Trial Posts Impressive Results
Roivant Sciences jumped to a new all-time high on Wednesday, as investors cheered impressive results from the third phase of its clinical trial for its drug treatment for an autoimmune...
Roivant Sciences Ltd. (ROIV) Wins Orphan Drug Status in Japan for Mosliciguat
Roivant Sciences Ltd.
7 Hot Healthcare Stocks to Buy Right Now
The majority of Americans have experienced the annoyance of having their health insurance rejected, frequently without any recourse after contacting carriers by email and phone...
13 Best Mid Cap Growth Stocks to Buy According to Hedge Funds
On August 26, Courtney Garcia, Payne Capital Management senior wealth advisor, joined CNBC television for an interview to discuss whether investors should continue buying in the...
Goldman Sachs Resumes Roivant Sciences (ROIV) Coverage with ‘Buy’ Rating
Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to buy according to billionaire Steve Cohen.
10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen
Steve Cohen, whose success at SAC Capital made him one of the most successful hedge fund managers on Wall Street, is a worried man.
Roivant Sciences Subsidiary Pulmovant Publishes Positive Phase 1 Data for Inhaled PH Treatment Mosliciguat
Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to invest in now.
13 Best Biotech Stocks To Invest In Now
In 2023, the global biotechnology market size was estimated at $1.55 trillion.
Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2024 Earnings Call Transcript
Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2024 Earnings Call Transcript May 29, 2025Roivant Sciences Ltd. misses on earnings expectations.
Why Roivant Sciences Ltd. (ROIV) Surged On Thursday
We recently published a list of While Wall Street Naps, These 10 Stocks Run Wild. In this article, we are going to take a look at where Roivant Sciences Ltd.
H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock
The reiteration comes after the company appointed the current President and COO of Roivant, Dr. Eric Venker as CEO of Immunovant. Roivant Sciences Ltd.
Billionaire David Einhorn’s 10 Stock Picks with Huge Upside Potential
David Einhorn is a widely renowned hedge fund manager who co-founded Greenlight Capital in 1996.
Billionaire Andreas Halvorsen’s 10 Stock Picks With Huge Upside Potential
Ole Andreas Halvorsen is one of the prominent names among former employees of Julian Robertson's Tiger Management.
Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn
Wall Street has come down crashing on President Donald Trump’s sweeping tariffs, raising the risk of a trade war that could push the global economy into recession.
10 Best Low Priced Growth Stocks To Invest In
Low priced stocks usually fall under the small to mid-cap size category.
10 Best Mid Cap Biotech Stocks to Buy
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
10 Best Stocks to Buy According to Billionaire David Einhorn
David Einhorn is a highly regarded hedge fund manager, who co-founded Greenlight Capital in 1996.
Does Roivant (ROIV) Offer an Attractive Risk Reward Opportunity?
Tourlite Capital Management, an investment management firm, released its fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Cash-Rich Mid Cap Stocks To Buy Now
Cash flow is the money moving in and out of a business over a set period.
10 Cheap Biotech Stocks to Invest in Now
Biotechnology stocks are among the most volatile in the market due to their high risk.
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2024 Earnings Call Transcript
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2024 Earnings Call Transcript February 10, 2025Roivant Sciences Ltd. beats earnings expectations.
Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
12 Best Medical Stocks To Buy Under $20
The medical industry plays a crucial role in ensuring the health and safety of populations.
10 Firms End 2024 Stronger With Impressive Gains
The Dow Jones Industrial Average dipped by 0.07 percent, the S&P 500 shed 0.43 percent, and the Nasdaq Composite declined by 0.90 percent.
Hedge Fund Resource Center
